This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Samyang Biopharmaceuticals Corporation. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovator Spotlight: Myung-Han Hyun from Seoul, KR
Introduction: Myung-Han Hyun is a prominent inventor based in Seoul, South Korea. His innovative work in the field of drug delivery showcases the importance of creative solutions in the pharmaceutical industry. He has successfully obtained a patent, demonstrating his role as a key player in the advancement of medical technology.
Latest Patents: Myung-Han Hyun holds a patent for an “Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery.” This groundbreaking invention pertains to an amphiphilic block copolymer with a hydrophilic block and a hydrophobic block characterized by a terminal hydroxyl group. Notably, the terminal hydroxyl group of the hydrophobic block is substituted with a tocopherol or cholesterol group. His invention also encompasses polymeric compositions that form stable micelles in aqueous solutions, enhancing drug delivery capabilities.
Career Highlights: Myung-Han Hyun is currently associated with Samyang Biopharmaceuticals Corporation, where he contributes his expertise to the development of innovative pharmaceutical solutions. His work emphasizes the importance of interdisciplinary approaches in creating effective drug delivery systems.
Collaborations: Throughout his career, Myung-Han Hyun has collaborated with talented coworkers, including Min Hyo Seo and Sa-Won Lee. These partnerships reflect the collaborative spirit of innovation and the shared goal of advancing drug delivery technology.
Conclusion: Myung-Han Hyun stands out as a notable innovator in the field of pharmaceutical sciences. His patent reflects a significant contribution to drug delivery systems, highlighting his role in enhancing medical therapies. As the industry continues to evolve, the innovative efforts of inventors like Myung-Han become increasingly vital in addressing healthcare challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
